Published in Endocr Rev on February 01, 1996
Paracrinicity: the story of 30 years of cellular pituitary crosstalk. J Neuroendocrinol (2008) 1.24
Pituitary adenylate cyclase-activating polypeptide (PACAP) mimics neuroendocrine and behavioral manifestations of stress: Evidence for PKA-mediated expression of the corticotropin-releasing hormone (CRH) gene. Brain Res Mol Brain Res (2005) 1.23
Crystal structure of the PAC1R extracellular domain unifies a consensus fold for hormone recognition by class B G-protein coupled receptors. PLoS One (2011) 1.16
Ion channels and signaling in the pituitary gland. Endocr Rev (2010) 1.14
Peptidergic activation of transcription and secretion in chromaffin cells. Cis and trans signaling determinants of pituitary adenylyl cyclase-activating polypeptide (PACAP). J Clin Invest (1998) 0.96
Mutational analysis of the human vasoactive intestinal peptide receptor subtype VPAC(2): role of basic residues in the second transmembrane helix. Br J Pharmacol (2001) 0.88
PACAP, an autocrine/paracrine regulator of gonadotrophs. Biol Reprod (2010) 0.86
Immunomodulation of innate immune responses by vasoactive intestinal peptide (VIP): its therapeutic potential in inflammatory disease. Clin Exp Immunol (2009) 0.86
PACAP modulation of the colon-inferior mesenteric ganglion reflex in the guinea pig. J Physiol (2004) 0.85
Interaction of gonadal steroids and gonadotropin-releasing hormone on pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP receptor expression in cultured rat anterior pituitary cells. Reprod Sci (2013) 0.83
Molecular mechanisms of gonadotropin-releasing hormone signaling: integrating cyclic nucleotides into the network. Front Endocrinol (Lausanne) (2013) 0.81
Identification of differentially expressed genes in the zebrafish hypothalamic-pituitary axis. Gene Expr Patterns (2009) 0.80
Structure-activity relationship of vasoactive intestinal peptide (VIP): potent agonists and potential clinical applications. Naunyn Schmiedebergs Arch Pharmacol (2008) 0.80
Expression analysis of PAC1-R and PACAP genes in zebrafish embryos. J Mol Neurosci (2010) 0.79
Dependence of the excitability of pituitary cells on cyclic nucleotides. J Neuroendocrinol (2012) 0.79
Pituitary adenylate-cyclase-activating polypeptide (PACAP) binding sites and PACAP/vasoactive intestinal polypeptide receptor expression in human pituitary adenomas. Am J Pathol (1998) 0.78
Role of PACAP in Female Fertility and Reproduction at Gonadal Level - Recent Advances. Front Endocrinol (Lausanne) (2012) 0.77
Transcriptional modulation by VIP: a rational target against inflammatory disease. Clin Epigenetics (2011) 0.76
Dopamine-2 receptor activation suppresses PACAP expression in gonadotrophs. Endocrinology (2014) 0.75
Pituitary adenylate cyclase-activating polypeptide inhibits transforming growth factor-beta1-induced apoptosis in a human pituitary adenoma cell line. Am J Pathol (1999) 0.75
Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science (1997) 15.12
Evolution of envelope sequences of human immunodeficiency virus type 1 in cellular reservoirs in the setting of potent antiviral therapy. J Virol (1999) 2.42
Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs. Endocrinology (1995) 0.85
PACAP, PACAP receptors, and intracellular signalling. Mol Cell Endocrinol (1994) 0.85
Pituitary adenylate cyclase-activating polypeptide increases [Ca2]i in rat gonadotrophs through an inositol trisphosphate-dependent mechanism. J Biol Chem (1994) 0.80